23.06.2023 • News

Enzene Biosciences Plans Biopharma Campus in USA

Indian CDMO Enzene Biosciences — a subsidiary of Alkem Laboratories — is to build a biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell, New Jersey, USA.

© Gary L Hider - stock.adobe.com
© Gary L Hider - stock.adobe.com

The facility will be Enzene’s first outside of India when it starts up in June 2024, initially employing 50 staff and expanding to 300 in the future.

Enzene said the New Jersey manufacturing capabilities will provide North American biopharmaceutical companies with streamlined supply chains, fast turnaround times, enhanced communication and greater control over the manufacturing process.

Located in Pune, Enzene is focused on producing biosimilars, novel biologics, synthetic peptides and phytopharmaceuticals.

Author: Elaine Burridge, Freelance Journalist

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read